Polaryx Therapeutics, Inc. Common Stock (PLYX) — Financial Flexibility Index
Polaryx Therapeutics, Inc. Common Stock (PLYX) has a Financial Flexibility Index of -1.74x as of December 2025. Free cash flow of $-1.49 Million (operating CF $-1.49 Million minus capex $0.00) represents -2% of total liabilities ($855.00K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Polaryx Therapeutics, Inc. Common Stock Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for Polaryx Therapeutics, Inc. Common Stock across 3 annual periods. See Polaryx Therapeutics, Inc. Common Stock (PLYX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Polaryx Therapeutics, Inc. Common Stock (2023–2025)
Year-by-year free cash flow to debt coverage for Polaryx Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see PLYX company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.61x | $-3.94 Million | $-3.94 Million | $855.00K | ▲ +48.2% |
| 2024 | -8.90x | $-2.57 Million | $-2.57 Million | $289.00K | ▼ -5241.9% |
| 2023 | -0.17x | $-173.00K | $-173.00K | $1.04 Million | — |